<DOC>
	<DOCNO>NCT02932007</DOCNO>
	<brief_summary>The goal pilot study explore efficacy chloroquine terminate persistent longstanding persistent AF ass potential role pharmacological cardioversion agent management AF .</brief_summary>
	<brief_title>Chloroquine Symptomatic Persistent Longstanding Persistent AF</brief_title>
	<detailed_description>This open-label , pilot study explore efficacy chloroquine terminate persistent longstanding persistent AF within 2 week drug administration ass potential role pharmacological cardioversion agent management AF . Subjects follow 2 week start drug administration study drug termination .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Age 18 year old Eligibility treatment chloroquine accord local label History symptomatic persistent longstanding persistent AF Persistent AF define continuous AF sustain 7 day less 12 month . Episodes AF ≥ 48 hour duration decision make terminate electrical pharmacological cardioversion prior 7 day also classify persistent AF Longstanding persistent AF define continuous AF &gt; 12 month ≤ 3years duration AF must document least either ECG , Holter monitoring , loop recorder , telemetry , transtelephonic monitoring , pacemaker cardiac defibrillator readout within 24 month prior enrollment Anticoagulation therapy indicate per local guideline , consider optimal stroke prevention opinion investigator Implanted dual chamber pacemaker/ICD willingness wear 2 week Holter monitor implant pacemaker/ICD Signed inform consent Age &lt; 18 year History paroxysmal AF Paroxysmal AF define recurrent AF ( ≥ 2 episode ) terminate spontaneously within 7 day . Episodes AF ≤ 48 hour duration terminate electrical pharmacological cardioversion also classify paroxysmal AF Permanent AF Permanent AF define ongoing AF &gt; 3 year duration AF felt secondary obvious reversible cause , limited , acute myocardial infarction , pulmonary embolism , recent surgery , pericarditis , alcohol intoxication , hypoxemia , thyrotoxicosis Structural heart disease Coronary heart disease Left ventricular dysfunction ejection fraction &lt; 50 % Prolonged QTc &gt; 440 msec baseline ECG Contraindications quinolines Known allergy chloroquine Use amiodarone 12 month prior enrollment History AF ablation within 30 day prior enrollment Renal failure require dialysis Significant intrinsic liver disease History alcohol abuse Preexisting auditory damage History epilepsy Women childbearing potential ( menstrual period previous 12 month ) : pregnant breastfeeding plan become pregnant study surgically sterile practice two acceptable method birth control , plan continue practice two acceptable method birth control throughout study ( highly effective method list section 6.0 Pregnancy ) Current participation another clinical study Serious active medical psychiatric condition , opinion investigator , may interfere treatment , assessment , compliance protocol Not able discontinue medication know significant interaction chloroquine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>persistent</keyword>
	<keyword>longstanding persistent</keyword>
</DOC>